Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LEADER: Glycemic Targets During CPB in Diabetic Elderly Cardiac Surgery
NCT07485101Not yet recruiting
- Sponsor
- Beijing An Zhen Hospital
- Start
- Apr 2026
- Primary completion
- Apr 2028
- Modality
- Recombinant Proteins and Enzymes
01
Overview
Randomised trial of insulin icodec in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Beijing An Zhen Hospital. Primary endpoint: Composite of major adverse cardio-cerebro-renal and vascular events at 30 days. Planned start Apr 2026; status: not yet recruiting.
02
Drugs
insulin icodec
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT07485101.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07485101.